Arcutis Biotherapeutics (ARQT) Change in Receivables (2022 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Change in Receivables of -$1.9 million for Q1 2026, down 115.0% year-over-year from $12.3 million in Q1 2025, and down 105.95% quarter-over-quarter from $31.1 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Change in Receivables (2022 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Change in Receivables history runs 5 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- In Q1 2026, Change in Receivables fell 115.0% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at $59.0 million (up 22.17% YoY), while the FY2025 annual figure was $73.2 million, up 54.81% from the prior year.
- Change in Receivables for Q1 2026 stood at -$1.9 million, down from $31.1 million in the prior quarter.
- The five-year high for Change in Receivables was $31.1 million in Q4 2025, with the low at -$1.9 million in Q1 2026.
- The 5-year median for Change in Receivables is $6.4 million (2023), against an average of $9.6 million.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables surged 651.54% in 2024, then slumped 115.0% in 2026.
- Arcutis Biotherapeutics' Change in Receivables stood at $6.0 million in 2022, then gained by 6.02% to $6.4 million in 2023, then surged by 121.06% to $14.1 million in 2024, then surged by 120.25% to $31.1 million in 2025, then sank by 105.95% to -$1.9 million in 2026.
- Business Quant data shows ARQT's Change in Receivables at -$1.9 million in Q1 2026, $31.1 million in Q4 2025, and $8.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 10.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.79 Mn |
| Jun 30, 2026 | 10.79 Mn |
| Mar 31, 2026 | -1.85 Mn |
| Mar 31, 2026 | -1.85 Mn |
| Dec 31, 2025 | 31.11 Mn |
| Dec 31, 2025 | 31.11 Mn |
| Sep 30, 2025 | 8.43 Mn |
| Sep 30, 2025 | 8.43 Mn |
| Jun 30, 2025 | 21.27 Mn |
| Jun 30, 2025 | 21.27 Mn |
| Mar 31, 2025 | 12.35 Mn |
| Mar 31, 2025 | 12.35 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Sep 30, 2024 | 16.61 Mn |
| Sep 30, 2024 | 16.61 Mn |
| Jun 30, 2024 | 5.18 Mn |
| Jun 30, 2024 | 5.18 Mn |
| Mar 31, 2024 | 11.35 Mn |
| Mar 31, 2024 | 11.35 Mn |